1. Home
  2. PSNL vs NFJ Comparison

PSNL vs NFJ Comparison

Compare PSNL & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Personalis Inc.

PSNL

Personalis Inc.

N/A

Current Price

$13.89

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Logo Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

NFJ

Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

N/A

Current Price

$15.72

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PSNL
NFJ
Founded
2011
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
PSNL
NFJ
Price
$13.89
$15.72
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
3.3M
191.4K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
9.01%
EPS Growth
33.58
N/A
EPS
N/A
N/A
Revenue
$69,648,000.00
N/A
Revenue This Year
$15.34
N/A
Revenue Next Year
$41.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.45
$12.25
52 Week High
$16.39
$15.73

Technical Indicators

Market Signals
Indicator
PSNL
NFJ
Relative Strength Index (RSI) 57.08 69.04
Support Level $6.89 $14.87
Resistance Level $14.81 N/A
Average True Range (ATR) 0.59 0.16
MACD 0.06 0.03
Stochastic Oscillator 79.03 98.31

Price Performance

Historical Comparison
PSNL
NFJ

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.

Share on Social Networks: